St. Jude Medical (STJ) – Will Fourth Quarter Predictions Ring True?

St. Jude Medical is a company dedicated to making medical tools and providing the services needed to give doctors better control in helping patients suffering from cardiovascular disease, neurological disease, and chronic pain. St. Jude hires more than 14,000 employees throughout the world. These employees work in the concentrated areas of cardiac rhythm management, atrial fibrillation, and cardiovascular and neuromodulation among others. Through providing the materials for these needs, the company has benefited greatly. Selling stocks at $38.19 on Monday January 11, they have drawn much attention to the public eye.

In 2010 St. Jude Medical is hoping for double digit earnings, however due to economic factors and high taxes on medical equipment, they are hoping to at least satisfy a more tangible goal of 15 percent of earnings per share. St. Jude’s goal in the fourth quarter is to have a profit between 61 cents – 63 cents per share from sales of 1.2 billion. St. Jude is predicting a full year revenue of 4.68 billion where as the analysts predict a 4.67 revenue.  Some of the more pricey equipment St. Jude has sold in the fourth quarter, attributing to their full year revenue, have been:

• Heart rhythm management devices – $698
• Millionimplantable cardioverter defibrillators (used to treat rapid heartbeats) – $395 million
• Pacemakers (which treat slow heartbeats) – $303 million.

*The fourth quarter results will be discussed Wednesday, January 27th, at 8:00 am Eastern Time. This call is being webcast by CCBN and can be accessed at St. Jude Medical’s web site at www.sjm.com.

Get Free Email Updates
Like this article? Enter your email address and click "Subscribe" to get the latest articles sent to your email for free. Your email will only be used for this daily update and you can unsubscribe anytime.

* Subscribe to our feed now, it's free!

Related Tags
STJ

No comments yet.

Please share your comment: